Fig. 1
From: Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway
Nrf2 is overexpressed in endometrial cancer. The expression pattern of Nrf2 in normal endometrium (n = 10), hyperplasia (n = 20) and endometrial cancer (n = 90) was assessed using IHC staining. Representative images were captured at 100× magnification (a). The IHC scores in endometrial lesion tissues compared with normal endometrial tissues are presented (b). *p < 0.05 compared with normal endometrial tissues. The expression pattern of Nrf2 in endometrial fresh tissue was determined by western blot (c)